413 related articles for article (PubMed ID: 35664963)
1. Gut mucosal microbiota profiles linked to colorectal cancer recurrence.
Huo RX; Wang YJ; Hou SB; Wang W; Zhang CZ; Wan XH
World J Gastroenterol; 2022 May; 28(18):1946-1964. PubMed ID: 35664963
[TBL] [Abstract][Full Text] [Related]
2. Differential Mucosal Microbiome Profiles across Stages of Human Colorectal Cancer.
Zhang M; Lv Y; Hou S; Liu Y; Wang Y; Wan X
Life (Basel); 2021 Aug; 11(8):. PubMed ID: 34440574
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive analysis of the microbiota composition and gene expression in colorectal cancer.
Zhang Q; Zhao H; Wu D; Cao D; Ma W
BMC Microbiol; 2020 Oct; 20(1):308. PubMed ID: 33050883
[TBL] [Abstract][Full Text] [Related]
4. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
[TBL] [Abstract][Full Text] [Related]
5. Altered intestinal microbiota associated with colorectal cancer.
Zhang H; Chang Y; Zheng Q; Zhang R; Hu C; Jia W
Front Med; 2019 Aug; 13(4):461-470. PubMed ID: 31250341
[TBL] [Abstract][Full Text] [Related]
6. Mucosa-associated microbiota signature in colorectal cancer.
Gao R; Kong C; Huang L; Li H; Qu X; Liu Z; Lan P; Wang J; Qin H
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2073-2083. PubMed ID: 28600626
[TBL] [Abstract][Full Text] [Related]
7. Network Analysis of Gut Microbiota Including Fusobacterium and Oral Origin Bacteria and Their Distribution on Tumor Surface, Normal Mucosa, and in Feces in Patients with Colorectal Cancer.
Ohashi A; Yamamura T; Nakamura M; Maeda K; Sawada T; Ishikawa E; Yamamoto K; Ishikawa T; Kakushima N; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M; Fujishiro M
Digestion; 2022; 103(6):451-461. PubMed ID: 36349755
[TBL] [Abstract][Full Text] [Related]
8. Comparison of human gut microbiota in control subjects and patients with colorectal carcinoma in adenoma: Terminal restriction fragment length polymorphism and next-generation sequencing analyses.
Kasai C; Sugimoto K; Moritani I; Tanaka J; Oya Y; Inoue H; Tameda M; Shiraki K; Ito M; Takei Y; Takase K
Oncol Rep; 2016 Jan; 35(1):325-33. PubMed ID: 26549775
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota profiles in feces and paired tumor and non-tumor tissues from Colorectal Cancer patients. Relationship to the Body Mass Index.
Tesolato S; Ortega-Hernández A; Gómez-Garre D; Claver P; De Juan C; De la Serna S; Paz M; Domínguez-Serrano I; Dziakova J; Rivera D; Torres A; Iniesta P
PLoS One; 2023; 18(10):e0292551. PubMed ID: 37796924
[TBL] [Abstract][Full Text] [Related]
10. Study of the Relationship between Microbiome and Colorectal Cancer Susceptibility Using 16SrRNA Sequencing.
Liu W; Zhang R; Shu R; Yu J; Li H; Long H; Jin S; Li S; Hu Q; Yao F; Zhou C; Huang Q; Hu X; Chen M; Hu W; Wang Q; Fang S; Wu Q
Biomed Res Int; 2020; 2020():7828392. PubMed ID: 32083132
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel gut microbiota signature associated with colorectal cancer in Thai population.
Iadsee N; Chuaypen N; Techawiwattanaboon T; Jinato T; Patcharatrakul T; Malakorn S; Petchlorlian A; Praditpornsilpa K; Patarakul K
Sci Rep; 2023 Apr; 13(1):6702. PubMed ID: 37095272
[TBL] [Abstract][Full Text] [Related]
12. Identification of KRAS mutation-associated gut microbiota in colorectal cancer and construction of predictive machine learning model.
Huang Z; Huang X; Huang Y; Liang K; Chen L; Zhong C; Chen Y; Chen C; Wang Z; He F; Qin M; Long C; Tang B; Huang Y; Wu Y; Mo X; Weizhong T; Liu J
Microbiol Spectr; 2024 May; 12(5):e0272023. PubMed ID: 38572984
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota signatures in tissues of the colorectal polyp and normal colorectal mucosa, and faeces.
Zhong X; Wang Y; Xu J; Cao H; Zhang F; Wang X
Front Cell Infect Microbiol; 2022; 12():1054808. PubMed ID: 36704106
[TBL] [Abstract][Full Text] [Related]
14. Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study.
Zhang Y; Yu X; Yu E; Wang N; Cai Q; Shuai Q; Yan F; Jiang L; Wang H; Liu J; Chen Y; Li Z; Jiang Q
BMC Microbiol; 2018 Aug; 18(1):92. PubMed ID: 30157754
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain.
Allali I; Delgado S; Marron PI; Astudillo A; Yeh JJ; Ghazal H; Amzazi S; Keku T; Azcarate-Peril MA
Gut Microbes; 2015; 6(3):161-72. PubMed ID: 25875428
[TBL] [Abstract][Full Text] [Related]
16. Enterotypical Prevotella and three novel bacterial biomarkers in preoperative stool predict the clinical outcome of colorectal cancer.
Huh JW; Kim MJ; Kim J; Lee HG; Ryoo SB; Ku JL; Jeong SY; Park KJ; Kim D; Kim JF; Park JW
Microbiome; 2022 Nov; 10(1):203. PubMed ID: 36443754
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the gut microbiome using extracellular vesicles in the urine of patients with colorectal cancer.
Yoon H; Kim NE; Park J; Shin CM; Kim N; Lee DH; Park JY; Choi CH; Kim JG; Park YS
Korean J Intern Med; 2023 Jan; 38(1):27-38. PubMed ID: 36353788
[TBL] [Abstract][Full Text] [Related]
18. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
[No Abstract] [Full Text] [Related]
19. Using gut microbiota as a diagnostic tool for colorectal cancer: machine learning techniques reveal promising results.
Lu F; Lei T; Zhou J; Liang H; Cui P; Zuo T; Ye L; Chen H; Huang J
J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37288545
[No Abstract] [Full Text] [Related]
20. 16S rRNA of Mucosal Colon Microbiome and CCL2 Circulating Levels Are Potential Biomarkers in Colorectal Cancer.
Nardelli C; Granata I; Nunziato M; Setaro M; Carbone F; Zulli C; Pilone V; Capoluongo ED; De Palma GD; Corcione F; Matarese G; Salvatore F; Sacchetti L
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]